Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Colombia
100%
Colombians
41%
Skin Cancer
32%
Risk Factors
28%
National Reference Center
17%
Health Systems
17%
Women with Breast Cancer
16%
Alopecia Areata
16%
Non-governmental Organizations
16%
Timely Treatment
16%
Systematic Literature Review
16%
Network Meta-analysis
16%
Odds Ratio
16%
Multidrug Therapy
12%
Confidence Interval
12%
Epidemiology
10%
Weighted kappa
10%
Basal Cell Carcinoma
10%
Interobserver Agreement
10%
Squamous Cell Carcinoma (SqCC)
10%
Leprosy
10%
Interobserver
10%
Epidemiological Characteristics
9%
Clinical Features
9%
Multivariate Analysis
9%
Clinical Diagnosis
8%
Inquiry-based
8%
Prison Population
8%
Knowledge-attitude-practice
8%
Betahistine
8%
Peripheral Vestibular Vertigo
8%
Cannabidiol
8%
Psoralen Plus Ultraviolet A
8%
Minimal Erythema Dose
8%
Fitzpatrick Skin Type
8%
Treatment of Women
8%
Female Reproductive Health
8%
Cutaneous Pathology
8%
Epidemiological Profile
8%
IL2RA
8%
Skin Cancer Risk Factors
8%
T2T Strategy
8%
Conventional Disease-modifying Antirheumatic Drug
8%
Cancer Healthcare
8%
Bacillary Index
8%
Hyperchloremia
8%
Mucosal Leishmaniasis
8%
High-titer Inhibitor
8%
Oral Isotretinoin
8%
Anti-tumor Necrosis Factor Therapy
8%
Medicine and Dentistry
Skin Cancer
30%
Reproducibility
20%
Prevalence
17%
Polypharmacy
16%
Health Care Cost
16%
Odds Ratio
16%
Dermatology
16%
Kappa Statistic
12%
Diseases
10%
Basal-Cell Carcinoma
10%
Squamous Cell Carcinoma
10%
Leishmaniasis
9%
Public Health
8%
Peripheral Vertigo
8%
Betahistine
8%
Skin Type
8%
Reproductive Public Health
8%
Hyperchloremia
8%
Patient with Hemophilia
8%
Skin Sensitivity
8%
Isotretinoin
8%
Acneiform Eruption
8%
Cohort Effect
8%
Methotrexate
8%
Recurrence Risk
8%
Sporotrichosis
8%
Erythema
8%
Cancer Risk Factor
8%
Cohort Analysis
8%
Primary Health Care
8%
Rheumatoid Arthritis
8%
Inflammatory Arthritis
8%
Cost-Effectiveness Analysis
8%
Syphilis
8%
Disease Modifying Antirheumatic Drug
8%
Adverse Event
8%
Haemophilia A
8%
Human immunodeficiency virus
8%
Intensive Care Unit
8%
Hepatitis B
8%
Health System
7%
Case-Control Study
5%
Disease Activity
5%
